EBGLYSS
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90824942
- Registration number
- 7706700
- Mark type
- Stylized text
- Filed
- 13 Jul 2021
- Published for opposition
- 26 Apr 2022
- Registered
- 25 Feb 2025
- Attorney of record
- Bruce W. Longbottom
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment, prevention and diagnosis of atopic dermatitis, autoimmune diseases and disorders, dermatological diseases and disorders, inflammation and inflammatory diseases and disorders
Owner
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
- Eli Lilly and Company, Indianapolis, IN, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Feb 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Feb 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Feb 2025 — ASSIGNED TO LIE
- 30 Jan 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Jan 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Jan 2025 — NON-FINAL ACTION E-MAILED
- 21 Jan 2025 — SU - NON-FINAL ACTION - WRITTEN
- 17 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Nov 2024 — USE AMENDMENT FILED
- 17 Jan 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Nov 2024 — TEAS STATEMENT OF USE RECEIVED